Infectious Disease Of Abdomen — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for infectious disease of abdomen. 34 active patents protecting 5 drugs from 4+ originators. First major cliff: 2031. Daily refresh.

5
Approved drugs
34
Active US patents
53/100
Avg vulnerability
—
Annual revenue covered

Originators in Infectious Disease Of Abdomen

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 13 patents Baxter 9 patents Tetraphase Pharms 8 patents Fresenius Kabi 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating infectious disease of abdomen. Each bar = one year. Y-axis scaled to peak year (7 patents).

1
26
4
28
3
29
3
30
7
31
4
32
1
33
2
36
4
37
1
38
4
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Merrem
Meropenem
 Pfizer 10 57 — 2031-08-08
Metro I.V. In Plastic Container
METRONIDAZOLE
 Baxter 9 58 — 2028-02-02
Xerava
ERAVACYCLINE DIHYDROCHLORIDE
 Tetraphase Pharms 8 35 — 2029-08-07
Tygacil
TIGECYCLINE
 Fresenius Kabi 4 49 — 2028-10-24
Cleocin T
CLINDAMYCIN PHOSPHATE
 Pfizer 3 68 — 2026-12-02

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
9789057 Cleocin T method of use 80 2026-12-02
8658678 Metro I.V. In Plastic Container method of use 75 2028-06-27
12478606 Merrem method of use 75 2038-01-08
12257236 Metro I.V. In Plastic Container method of use 75 2039-01-16
12533342 Merrem method of use 75 2039-05-20
11129896 Cleocin T method of use 70 2036-09-22
11376237 Merrem method of use 70 2039-04-06
8796245 Xerava method of use 68 2029-08-07
8796245 Xerava method of use 68 2029-08-07
10561675 Merrem method of use 68 2031-08-08

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8680136 Merrem composition of matter 10 2031-08-29
10961190 Xerava composition of matter 12 2037-10-19
11578044 Xerava composition of matter 12 2037-10-19
11578044 Xerava composition of matter 12 2037-10-19
10961190 Xerava composition of matter 12 2037-10-19
12171772 Merrem composition of matter 23 2031-08-08
9855335 Tygacil formulation 42 2033-04-07
10596155 Metro I.V. In Plastic Container formulation 42 2032-06-28
10238634 Metro I.V. In Plastic Container formulation 42 2032-06-28
10172874 Merrem formulation 48 2031-08-08

Related